VulnerabilityModified
CVE-2020-27266
In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, a client-side control vulnerability in the insulin pump and its AnyDana-i and AnyDana-A mobile applications allows physically proximate attackers to bypass user authentication checks…
MEDIUM 6.5EPSS 0.58%
Does this matter?
Lower severity and a low EPSS score (0.58%). Track it; it rarely justifies an emergency change on its own.
Description
In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, a client-side control vulnerability in the insulin pump and its AnyDana-i and AnyDana-A mobile applications allows physically proximate attackers to bypass user authentication checks via Bluetooth Low Energy.
- CVSS 3.1
- 6.5 MEDIUMCVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
- EPSS
- 0.58% probability · 46th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-603, CWE-287
- Affected
- sooil/anydana-a firmware · sooil/anydana-i firmware · sooil/diabecare rs firmware
- Source
- ics-cert@hq.dhs.gov
References
- https://us-cert.cisa.gov/ics/advisories/icsma-21-012-01Third Party Advisory, US Government Resource
- https://us-cert.cisa.gov/ics/advisories/icsma-21-012-01Third Party Advisory, US Government Resource
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.